Abstract

We have developed a new idea to synthesize a key intermediate molecule by utilizing deep eutectic solvent (DES) and ultrasound in a multistep reaction to ensure process cost-effectiveness. To confirm the stability of reagents with DES, electronic energies were calculated at the B3LYP/6-31+G(d,p) level of theory. DES stabilized the reagents mainly due to strong intermolecular hydrogen bonding. Key intermediate (3) and final compounds (4a–n) were synthesized in a higher yield of 95% and 80%–88%, respectively. Further, final compounds (4a–n) were assessed for their anti-inflammatory, analgesic, ulcerogenic, and lipid peroxidation. The compounds 4f, 4g, 4j, 4l, and 4m showed good anti-inflammatory activity, while 4f, 4i, and 4n exhibited very good analgesic activity as compared to the standard drug. The ulcerogenicity of selected compounds was far less than the indomethacin. The ligands had also shown a good docking score (4f = −6.859 kcal/mol and 4n = −7.077 kcal/mol) as compared to control indomethacin (−6.109 kcal/mol) against the target protein COX-2. These derivatives have the potential to block this enzyme and can be used as NSAID. The state-of-art DFT theory was used to validate the lipid peroxidation mechanism of the active compounds which was in good agreement with the variations of BDEs and IP of the tested compounds.

Highlights

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are a profound application for the treatment of inflammatory diseases and pain

  • We have examined the lipid peroxidation (LP) of compounds which exhibited maximum anti-inflammatory and analgesic activities (4c, 4f, 4i, 4n)

  • Only the synthesized derivatives (In-H) that exhibited maximum anti-inflammatory and analgesic activities derivatives are subjected to the lipid peroxidation (LP)

Read more

Summary

Introduction

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a profound application for the treatment of inflammatory diseases and pain. The COX-2 is an inducible enzyme that works through the mediation of the selective inflammatory signal and the therapeutic anti-inflammatory action of NSAIDs is produced by the inhibition of COX-2 [10,11,12,13,14]. Based on this observation, many selective COX-2 inhibitors such as celecoxib, rofecoxib, and valdecoxib emerged as relatively safe NSAID’S together with improved gastric problems. The reporting of the cardiovascular side effects, for example, increased risk of myocardial infarction, stroke, heart failure, and hypertension caused the withdrawal of many COX-2 inhibitors from the market [15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call